Coinbase
COIN
Tesla
TSLA
NVIDIA
NVDA
Amazon
AMZN
Meta Platforms
META
US Stock MarketDetailed Quotes
LRMR Larimar Therapeutics
- 2.810
- -0.070-2.43%
Trading Mar 11 10:00 ET
179.30MMarket Cap-2.44P/E (TTM)
2.950High2.800Low30.47KVolume2.920Open2.880Pre Close87.18KTurnover0.10%Turnover RatioLossP/E (Static)63.81MShares11.20052wk High0.90P/B87.46MFloat Cap2.52252wk Low--Dividend TTM31.13MShs Float664.320Historical High--Div YieldTTM5.21%Amplitude1.530Historical Low2.861Avg Price1Lot Size
About Larimar Therapeutics Company
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Company Profile
SymbolLRMR
Company NameLarimar Therapeutics
Listing DateJun 19, 2014
Issue Price16.00
Founded2005
CEODr. Carole Ben-Maimon, M.D.
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address3 Bala Plaza East,Suite 506
CityBala Cynwyd
ProvincePennsylvania
CountryUnited States of America
Zip Code19004
Phone1-844-511-9056
Websitehttp://larimartx.com
Company Executives
- Name
- Position
- Salary
- Dr. Carole Ben-Maimon, M.D.
- Director, President and Chief Executive Officer
- 3.14M
- Michael Celano
- Chief Financial Officer and Principal Accounting Officer
- 1.42M
- Dr. Russell G. Clayton, D.O.
- Chief Medical Officer
- --
- Dr. Gopi Shankar, F.A.A.P.,M.B.A.,PhD
- Chief Development Officer
- 1.38M
- Joseph Truitt
- Chairman of the Board
- 114.96K
- Thomas Edward Hamilton
- Independent Director
- 77.77K
- Jonathan S. Leff
- Independent Director
- 79.96K
- Frank E. Thomas
- Independent Director
- 86.21K
- Dr. Jeffrey W. Sherman, F.A.C.P.,M.D.
- Independent Director
- 56.43K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.